Savara Pharmaceuticals
SVRA
#6617
Rank
C$0.79 B
Marketcap
$4.61
Share price
-1.23%
Change (1 day)
-25.09%
Change (1 year)

Savara Pharmaceuticals (SVRA) - Cash on Hand

Cash on Hand as of September 2024 : C$0.31 Billion

According to Savara Pharmaceuticals's latest financial reports the company has C$0.31 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Savara Pharmaceuticals - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$0.21 B26.04%
2022-12-31C$0.17 B-16.84%
2021-12-31C$0.20 B96%
2020-12-31C$0.10 B-34.1%
2019-12-31C$0.15 B5.34%
2018-12-31C$0.15 B27.32%
2017-12-31C$0.11 B559.8%
2016-12-31C$17.97 M-68.39%
2015-12-31C$56.84 M-14.49%
2014-12-31C$66.48 M40.69%
2013-12-31C$47.25 M30.15%
2012-12-31C$36.3 M-29.6%
2011-12-31C$51.57 M84.41%
2010-12-31C$27.96 M206.67%
2009-12-31C$9.11 M-23.85%
2008-12-31C$11.97 M-64.12%
2007-12-31C$33.38 M-44.59%
2006-12-31C$60.24 M129.04%
2005-12-31C$26.3 M68.04%
2004-12-31C$15.65 M185.51%
2003-12-31C$5.48 M3240.05%
2002-12-31C$0.16 M-37.35%
2001-12-31C$0.26 M-88.22%
2000-12-31C$2.22 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$23.47 M-92.53%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.58 B 85.20%๐Ÿ‡บ๐Ÿ‡ธ USA